WOOD DALE, IL--(Marketwire - November 23, 2009) - SANYO North America's Biomedical and
Environmental Division has released a new
whitepaper showing that higher
up-time ratios, based on new protocols that minimize incubator downtime
when compared to conventional decontamination methods, can accelerate a
return on investment in cell culture CO2 incubators that use hydrogen peroxide vapor
(H2O2) in conjunction with narrow-bandwidth ultraviolet light and
copper-enriched stainless steel. The return on investment favors short,
labor-saving sterilization cycles while the need for interior sterilization
prior to initiating applications related to in vitro fertilization, stem
cell research and regenerative tissue culture is more frequent than
longer-term cell culture work.
The whitepaper outlines how the use of a hydrogen peroxide vapor (H2O2)
atomizer in situ to decontaminate the cell culture CO2 incubator without
the use of heat sterilization can offer significant advantages in routine
clinical and highly-regulated research laboratories where downtime is
costly and should be avoided. Leaving only minute residual amounts of
sterile water condensate and trace oxygen, the combination of a ten-minute
H2O2 vapor fog in the chamber, circulated by the incubator airflow blower,
followed by exposure to narrow-bandwidth ultraviolet light establishes a
thorough antimicrobial impact on all incubators' walls, shelves,
reservoirs, air plenums, sensors and other interior components without the
time and expense required by high heat cycles. Since all interior
components are easily reconfigured to remain in the chamber for
sterilization during the process, use of a separate autoclave is avoided
and the incubator can be returned to service within three hours.
The results shown in the whitepaper conclude that the SANYO up time
advantage ensures maximum productivity.
Deepak Mistry, Strategic Marketing Manager said, "The three-hour in situ
sterilization sequence puts the SANYO Sterisonic GxP incubator
online more quickly and with greater efficiency than competitive models
using high heat or other decontamination protocols. In applications that
require frequent sterilization between processes, the SANYO Sterisonic GxP
demonstrates a significant up time advantage for maximum productivity."
To learn more, download the whitepaper at www.sterisonic.com.
SANYO Electric Co., Ltd. (PINKSHEETS: SANYY) is a multi-billion dollar,
global leader in providing solutions for the environment, energy and for
lifestyle applications based on its brand vision, 'Think GAIA'. SANYO Biomedical and Environmental
Solutions (a division of SANYO North America Corporation, a subsidiary
of SANYO Electric Co., Ltd.), based in Wood Dale, IL, provides laboratory
equipment for pharmaceutical, life science and biotechnology applications.
Product lines include space-efficient VIP® ultra-low temperature
freezers, cryogenic freezers, pharmaceutical and medical refrigerators,
cell culture incubators, plant growth chambers, and portable autoclaves.
For more information on SANYO, please visit http://us.sanyo.com.